InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Campbell Shannon. Director active across 2 companies, notably Black Diamond Therapeutics, Inc.. Aggregated, 4 reports have been logged. History available since 21 June 2024. The latest transaction was disclosed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Campbell Shannon is a declarant and a Director at Black Diamond Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. He has 4 filings in total, and the sampled recent filings run from 2024-06-21 to 2026-05-27, with buy and sell amounts of EUR 0 each. The modal transaction nature is Attribution.